-
60 Degrees Pharmaceuticals Awarded U.S. Patent Covering Tafenoquine for Treatment of COVID-19 and Other Lung Infections
26 Apr 2023 11:34 GMT
… COVID-19 Clinical trial data suggesting the ARAKODA … dreams, and anxiety. Drug Interactions Avoid co-administration … distributing new medicines for the treatment and prevention of … specialty pharmaceutical company that obtained FDA approval for Impavido, a …
-
Saving lives: Drug, new test pushed to treat brain-eating amoeba
16 Dec 2022 13:31 GMT
… #47; Graham Media Group)Doctors at AdventHealth in Orlando immediately … the CEO of Profounda Pharmaceuticals in Orlando. Aside from … distributor of Impavido – the only known drug that kills this … both Jordan and Sebastian, doctors at AdventHealth were concerned …
-
Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results
21 Mar 2024 11:30 GMT
… innovative and branded generic pharmaceuticals products. With our strong … as higher demand for Impavido®. The increase included $ … agent, a nonstimulant medication for the treatment of Attention-Deficit … trials,1-4 QelbreeTM was approved by the US Food and Drug …
-
Thérapeutique Knight publie ses résultats du quatrième trimestre et de fin d'année 2023
21 Mar 2024 11:30 GMT
… ou la « Société »), société pharmaceutique spécialisée panaméricaine (hors États-Unis … de la demande pour Impavido®. L’augmentation comprend … et des initiatives médicales liées aux principaux … Extended-release) in the Treatment of Attention-deficit…
-
FDA Grants Profounda Orphan Drug Designation Approval for treatment of Treatment of Invasive Candidiasis with Miltefosine
08 Nov 2021 23:18 GMT
… Leishmaniasis is a parasitic disease that is … treatment".
About Impavido® (miltefosine)
Impavido® (miltefosine) is an FDA-approved, oral treatment … oriented, privately backed pharmaceutical company that aims … that take our medication. Profounda' …
-
60° Pharmaceuticals (60P) Submits New Drug Application to US FDA for Antimalarial Drug Tafenoquine
15 Jan 2018 06:03 GMT
… Treatment for Malaria, Malaria Prophylaxis60° Pharmaceuticals (60P) Submits New Drug Application to US FDA … by Plasmodium parasites that … distributing new medicines for treatment and prevention … pharmaceutical company that obtained FDA approval for Impavido, …
-
60° Pharmaceuticals (60P) Submits New Drug Application to US FDA for Antimalarial Drug Tafenoquine
18 Dec 2017 15:20 GMT
… caused by Plasmodium parasites that are transmitted … five clinical trials to assess the safety … and distributing new medicines for treatment and prevention of tropical … Canadian specialty pharmaceutical company that obtained FDA approval for Impavido, a …
-
Global Leishmaniasis Treatment Market Is Expected to Reach USD 223.88 million by 2027 : Fior Markets
27 Aug 2020 04:09 GMT
… of Impavido, approved by FDA, and oral treatment for mucosal … an agreement with Drugs for neglected disease … into serological tests, parasitological evaluation, DNA-based methods … including industries like technology, pharmaceutical, consumer goods, food …
-
Proton Pump and VEGF Inhibitors Among Adds to FDA Watch List
30 Jul 2020 22:54 GMT
… Drug Administration (FDA) includes almost two dozen drugs or drug … bariatric surgery: treatment failure
FDA is evaluating the … action.
Miltefosine (Impavido)
Eye disorders
FDA is evaluating … Myxredlin)
Medication error: labeling confusion
FDA is evaluating …
-
Canadian blinded by water-borne parasite outraged by medication cost
17 Jul 2019 20:16 GMT
… vicious” relapse.
“A doctor at Toronto General prescribed … Miltefosine for these treatments. The current manufacturer supplying the drug … told CTVNews.ca that Impavido (Mitlefosine) is approved …
“Acanthamoeba is a parasite which is actually ubiquitous, …